Feedback / Questions
Ongentys (opicapone) - Ono Pharma, Neurocrine, BIAL
https://www.prnewswire.com/news-releases/neurocrine-biosciences-reports-first-quarter-2023-financial-results-301814198.html
May 3, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next